Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
Published on: October 20, 2023
Targeting neurological disease with RNAi
1Dept. of Neurology, Georg-August-University Göttingen, Faculty of Medicine, Waldweg 33, 37073 Göttingen, Germany. plingor@gwdg.de
RNA interference (RNAi) is a powerful tool for studying gene function in neuroscience. This review covers RNAi design, delivery, potential side effects, and its application in neurological disease models and future clinical therapy.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- RNA interference (RNAi) is widely used in neuroscientific research for gene function analysis.
- Short interfering RNA (siRNA) and short hairpin RNA (shRNA) are key tools for gene silencing.
Purpose of the Study:
- To discuss advances in the technical implementation of RNAi for gene silencing.
- To summarize the current applications of RNAi in neurological disease models.
- To provide an outlook on RNAi's clinical therapeutic potential.
Main Methods:
- Review of recent advances in siRNA/shRNA design and delivery.
- Analysis of potential detrimental effects associated with RNAi.
- Summary of RNAi's use in preclinical models of neurological diseases.
Main Results:
- RNAi techniques have been refined for improved design and delivery.
- Potential off-target effects and other detrimental aspects of RNAi are being addressed.
- RNAi shows promise in targeting various neurological disease models.
Conclusions:
- RNAi is a valuable tool for neuroscience research and understanding gene function.
- Further development is needed to optimize RNAi for safe and effective clinical applications.
- RNAi holds significant potential for future therapeutic strategies in neurology.
Related Concept Videos
06:19Reconstruction of the Blood-Brain Barrier In Vitro to Model and Therapeutically Target Neurological Disease
03:24RNAi Plating for C. elegans Feeding: A Technique to Induce Target dsRNA Expression in E. coli
RNAi in C. elegans
09:58Lipidomics and Transcriptomics in Neurological Diseases
06:49A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
07:56Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

